Hemcheck's IPO

Hemcheck raised a round of funding on March 15, 2017. Investors include Public.

Hemcheck Sweden is a medical technology company addressing the issue of hemolysis – the most common reason for blood samples to be deemed unfit for laboratory analysis. Hemcheck Sweden is doing this…

Articles about Hemcheck's IPO: